Related references
Note: Only part of the references are listed.Mortality in schizophrenia: 30-year nationwide follow-up study
A. Tanskanen et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
Cardiometabolic risks and omega-3 index in recent-onset bipolar I disorder
Lawson R. Wulsin et al.
BIPOLAR DISORDERS (2018)
Cardiometabolic risk factors, physical activity and psychiatric status in patients in long-term psychiatric inpatient departments
Petter Andreas Ringen et al.
NORDIC JOURNAL OF PSYCHIATRY (2018)
Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder
Ina H. Heiberg et al.
PLOS ONE (2018)
Metabolic syndrome in patients with bipolar disorder treated with atypical antipsychotics, their first-degree relatives and control group
S. Arya et al.
EUROPEAN PSYCHIATRY (2017)
Metabolic syndrome in subjects with bipolar disorder and major depressive disorder in a current depressive episode: Population-based study Metabolic syndrome in current depressive episode
Fernanda Pedrotti Moreira et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016
Haidong Wang et al.
LANCET (2017)
Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis
Christoph U. Correll et al.
ANNALS OF GENERAL PSYCHIATRY (2017)
Diagnosis and body mass index effects on hippocampal volumes and neurochemistry in bipolar disorder
D. J. Bond et al.
TRANSLATIONAL PSYCHIATRY (2017)
Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014
Joseph F. Hayes et al.
BRITISH JOURNAL OF PSYCHIATRY (2017)
Twenty-year progression of body mass index in a county-wide cohort of people with schizophrenia and bipolar disorder identified at their first episode of psychosis
Martin Strassnig et al.
BIPOLAR DISORDERS (2017)
Metabolic syndrome and cardiovascular risk among institutionalized patients with schizophrenia receiving long term tertiary care
Lee Seng Esmond Seow et al.
COMPREHENSIVE PSYCHIATRY (2017)
Decline in Cardiovascular Mortality Possible Causes and Implications
George A. Mensah et al.
CIRCULATION RESEARCH (2017)
Trends in Modifiable Risk Factors Are Associated With Declining Incidence of Hospitalized and Nonhospitalized Acute Coronary Heart Disease in a Population
Jan Mannsverk et al.
CIRCULATION (2016)
Cardiovascular risk factors among patients with schizophrenia, bipolar, depressive, anxiety, and personality disorders
M. Perez-Pinar et al.
EUROPEAN PSYCHIATRY (2016)
Motivating factors and barriers towards exercise in severe mental illness: a systematic review and meta-analysis
J. Firth et al.
PSYCHOLOGICAL MEDICINE (2016)
Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis
Davy Vancampfort et al.
WORLD PSYCHIATRY (2016)
Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia
D. K. Solberg et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Metabolic syndrome in patients with bipolar disorder: Comparison with major depressive disorder and non-psychiatric controls
Barbora Silarova et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2015)
Comparisons of Different Metabolic Syndrome Definitions and Associations with Coronary Heart Disease, Stroke, and Peripheral Arterial Disease in a Rural Chinese Population
Jiangping Wen et al.
PLOS ONE (2015)
Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort
O. Godin et al.
SCHIZOPHRENIA RESEARCH (2015)
Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
Davy Vancampfort et al.
WORLD PSYCHIATRY (2015)
Childhood trauma mediates the association between ethnic minority status and more severe hallucinations in psychotic disorder
A. O. Berg et al.
PSYCHOLOGICAL MEDICINE (2015)
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
MARC DE HERT et al.
World Psychiatry (2015)
Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder
Adam Wysokinski et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2015)
Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population
Michael J. Bly et al.
BIPOLAR DISORDERS (2014)
Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia
Colin A. Depp et al.
BIPOLAR DISORDERS (2014)
Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders Baseline Results From the RAISE-ETP Study
Christoph U. Correll et al.
JAMA PSYCHIATRY (2014)
A Comprehensive Review on Metabolic Syndrome
Jaspinder Kaur
CARDIOLOGY RESEARCH AND PRACTICE (2014)
Barriers and Facilitators of a Healthy Lifestyle Among Persons with Serious and Persistent Mental Illness: Perspectives of Community Mental Health Providers
Christine L. McKibbin et al.
COMMUNITY MENTAL HEALTH JOURNAL (2014)
Improved Detection of Common Variants Associated with Schizophrenia by Leveraging Pleiotropy with Cardiovascular-Disease Risk Factors
Ole A. Andreassen et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Excess Mortality, Causes of Death and Life Expectancy in 270,770 Patients with Recent Onset of Mental Disorders in Denmark, Finland and Sweden
Merete Nordentoft et al.
PLOS ONE (2013)
Primary Care Providers' Views on Metabolic Monitoring of Outpatients Taking Antipsychotic Medication
Christina Mangurian et al.
PSYCHIATRIC SERVICES (2013)
Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder
P. Andreas Ringen et al.
SCHIZOPHRENIA RESEARCH (2013)
Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis
Alex J. Mitchell et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Life expectancy and cardiovascular mortality in persons with schizophrenia
Thomas M. Laursen et al.
CURRENT OPINION IN PSYCHIATRY (2012)
Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices
A. J. Mitchell et al.
PSYCHOLOGICAL MEDICINE (2012)
Chronic Somatic Comorbidity and Excess Mortality Due to Natural Causes in Persons with Schizophrenia or Bipolar Affective Disorder
Thomas Munk Laursen et al.
PLOS ONE (2011)
Neurocognitive Dysfunction in Bipolar and Schizophrenia Spectrum Disorders Depends on History of Psychosis Rather Than Diagnostic Group
Carmen Simonsen et al.
SCHIZOPHRENIA BULLETIN (2011)
Implementing clinical guidelines in psychiatry: a qualitative study of perceived facilitators and barriers
Tord Forsner et al.
BMC PSYCHIATRY (2010)
Metabolic side effects of antipsychotic drug treatment - pharmacological mechanisms
Gavin P. Reynolds et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Gender differences in antipsychotic prescribing
Shubulade Smith
INTERNATIONAL REVIEW OF PSYCHIATRY (2010)
Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
M. De Hert et al.
EUROPEAN PSYCHIATRY (2009)
Secondary Effects of Antipsychotics: Women at Greater Risk Than Men
Mary V. Seeman
SCHIZOPHRENIA BULLETIN (2009)
Neuropsychological Function and Dysfunction in Schizophrenia and Psychotic Affective Disorders
Abraham Reichenberg et al.
SCHIZOPHRENIA BULLETIN (2009)
Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics
Christoph U. Correll et al.
BIPOLAR DISORDERS (2008)
A systematic review of mortality in schizophrenia - Is the differential mortality gap worsening over time?
Sukanta Saha et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: A comparative study
Astrid B. Birkenaes et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Gaps between knowing and doing: Understanding and assessing the barriers to optimal health care
Lorna J. Cochrane et al.
JOURNAL OF CONTINUING EDUCATION IN THE HEALTH PROFESSIONS (2007)
Generalizability studies of the Global Assessment of Functioning-Split version
Geir Pedersen et al.
COMPREHENSIVE PSYCHIATRY (2007)
Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
KGMM Alberti et al.
DIABETIC MEDICINE (2006)
Sociodemographic characteristics and cardiovascular risk factors in patients with severe mental disorders compared with the general population
AB Birkenaes et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial and comparison with national estimates from NHANES III
JP McEvoy et al.
SCHIZOPHRENIA RESEARCH (2005)
Use of general medical services among medicaid patients with severe and persistent mental illness
PJ Salsberry et al.
PSYCHIATRIC SERVICES (2005)
Consensus development conference on antipsychotic drugs and obesity and diabetes
DIABETES CARE (2004)
The prevalence of the metabolic syndrome in patients with schizoaffective disorder - bipolar subtype
R Basu et al.
BIPOLAR DISORDERS (2004)
Physical health monitoring of patients with schizophrenia
SR Marder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia
MCM Ryan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Overweight and obesity as determinants of cardiovascular risk - The Framingham experience
PWF Wilson et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Physical consequences of schizophrenia and its treatment - The metabolic syndrome
MCM Ryan et al.
LIFE SCIENCES (2002)
Information about migraine disability influences physicians' perceptions of illness severity and treatment needs
WF Holmes et al.
HEADACHE (2001)
Share Paper
